Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study-Reference-Cited by-同舟云学术

Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study

Published:2018-09-14 Issue:20 Volume:124 Page:4056-4063
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Stacchiotti Silvia¹^ORCID,Morosi Carlo²,Lo Vullo Salvatore³^ORCID,Casale Alessandra²,Palassini Elena¹,Frezza Anna Maria¹,Dinoi Gabriella¹,Messina Antonella²,Gronchi Alessandro⁴,Cavalleri Adalberto⁵,Venturelli Elisabetta⁵,Morelli Daniele⁶,Pilotti Silvana⁶,Collini Paola⁶,Brich Silvia⁶,Tamborini Elena⁶,Mariani Luigi³^ORCID,Casali Paolo G.¹⁷

Affiliation:

1. Medical Oncology Unit 2, Medical Oncology DepartmentFondazione IRCCS Istituto Nazione dei Tumori Milan Italy

2. Radiology DepartmentFondazione IRCCS Istituto Nazione dei Tumori Milan Italy

3. Unit of Clinical Epidemiology and Trial OrganizationFondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

4. Department of SurgeryFondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

5. Research DepartmentFondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

6. Diagnostic Pathology and Laboratory Medicine DepartmentFondazione IRCCS Istituto Nazionale Tumori Milan Italy

7. Oncolgy and Hemato‐Oncology DepartmentUniversity of Milan Milan Italy

Funder

Italian Ministry of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31685

Reference18 articles.

1. Building a global consensus approach to chordoma: a position paper from the medical and patient community

2. Best practices for the management of local‐regional recurrent chordoma. A position paper by the Chordoma Global Consensus Group. Ann;Stacchiotti S;Oncology,2017

3. Medical treatment of advanced chordomas

4. Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas

5. Response to imatinib plus sirolimus in advanced chordoma

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of immunotherapy in treatment refractory chordomas: review of current evidence;Frontiers in Surgery;2024-05-30

2. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol;Neurosurgical Focus;2024-05

3. A retrospective study on the mechanism underlying quick transfer from response to resistance in a repeated recurrent chordoma patient with molecular alterations treated with Palbociclib;Journal of Cancer Research and Clinical Oncology;2024-02-19

4. Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma;Clinical Cancer Research;2023-12-04

5. Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study;ESMO Open;2023-06